Ep. 37: Professor Justin Stebbing On Vaccine Breakthroughs And Herd-Immunity By Summer

This episode is supported by private equity platform Moonfare.

In this show, I talk with Professor Justin Stebbing. I had him as a guest in July when he argued that we could see a COVID vaccine around US election time. He was right and so I wanted to get his latest views. For background, Justin is a professor in the Faculty of Medicine at Imperial college London. He specializes in cancers and immunotherapies. He has an extensive research background having published over 550 peer-reviewed papers. Earlier this year, he published in the Lancet new research on using AI to find drugs to treat COVID-19 and recently published in Foreign Affairs China’s global role in vaccine distribution. In this podcast we discuss:

1. The significance of Pfizer’s 90% efficacy rate

2. Vaccines from other pharma companies including from Russia & China

3. The science of vaccines – B-cell and T-cell responses

4. Fast tracking of vaccine approval by FDA

5. Managing public opinion and anti-vaxxers

6. Logistics of vaccine distribution

7. When will we get to herd-immunity

8. Remaining uncertainties around vaccines

9. Mink factories and mutations

10. Long COVID and athletes

11. Which countries have secured vaccine supplies

You can contact Justin on his Imperial page.

Make sure to subscribe to the show on Apple, Spotify, YouTube, or wherever you go for your podcasts. You can follow us on Twitter and LinkedIn.

(The commentary contained in the above article does not constitute an offer or a solicitation, or a recommendation to implement or liquidate an investment or to carry out any other transaction. It should not be used as a basis for any investment decision or other decision. Any investment decision should be based on appropriate professional advice specific to your needs.)